Tag Archives: real-world evidence

A look back at the ISPOR Annual International Meeting

Last week, participants from across our enterprise gathered in Philadelphia to contribute to the 20th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) conference. ISPOR advances the policy, science, and practice of pharmacoeconomics (or health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being, including […]
Read More »

The Power of Real-World Evidence

Next week, May 16 – 20, Optum colleagues, clients, industry peers, global researchers and thought leaders are gathering in Philadelphia at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting. I’m looking forward to convening with our clients, discussing our progress and brainstorming about the new challenges to be tackled. Reflecting […]
Read More »

ISPOR, Optum and the Power of Real-World Data

The life sciences industry is facing unprecedented opportunities and challenges, and I’m excited. We’re entering new and diverse markets, unlike any we’ve experienced before, while at the same time the dynamics in existing markets are becoming more complex due to health care transformation efforts.